Literature DB >> 8724013

How is expression of the interleukin-5 gene regulated?

S Karlen1, V A Mordvinov, C J Sanderson.   

Abstract

Eosinophilia is a uniquely specific phenomenon regulated by interleukin-5 (IL-5), suggesting specific control for IL-5 expression. However in eosinophilia IL-5 is often co-expressed with other lymphokines such as IL-4, indicating that common, as well as independent, control mechanisms must exist. IL-5 gene expression is regulated at the transcriptional level. The molecular analysis of the IL-5 promoter region reveals the presence of positive regulatory sites that are common to many lymphokine genes. Results from immunosuppression studies suggest that the key control mechanism of IL-5 regulation may not depend on specific regulatory factors but on how gene expression is activated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724013     DOI: 10.1038/icb.1996.31

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  3 in total

1.  Anti-interleukin 5 strategies as a potential treatment for asthma.

Authors:  A D Singh; C J Sanderson
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

2.  Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.

Authors:  O Kaminuma; A Mori; K Ogawa; H Kikkawa; A Nakata; K Ikezawa; H Okudaira
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33.

Authors:  J D Rioux; V A Stone; M J Daly; M Cargill; T Green; H Nguyen; T Nutman; P A Zimmerman; M A Tucker; T Hudson; A M Goldstein; E Lander; A Y Lin
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.